Deutsche Bank maintains Celanese stock Buy rating ahead of Q4 results

Published 21/01/2025, 13:08
Deutsche Bank maintains Celanese stock Buy rating ahead of Q4 results

Tuesday, Deutsche Bank (ETR:DBKGn) analysts maintained a Buy rating on shares of Celanese Corporation (NYSE:CE) with a steady price target of $85.00. The firm anticipates the forthcoming Q4 earnings announcement, scheduled for February 18, to serve as a pivotal event, potentially propelling the stock forward.

According to InvestingPro data, the stock currently trades at an attractive P/E ratio of 7.26x and appears undervalued based on comprehensive Fair Value analysis. With a new CEO at the helm since mid-December, the analysts expect the Q4 report to present conservative earnings guidance for 2025, with Deutsche Bank estimating $8.50 per share compared to the consensus of $8.89.

Despite recent challenges, including a significant 47% decline over the past six months, InvestingPro analysis shows the company maintains a GOOD financial health score, supported by its impressive 20-year track record of consistent dividend payments. Moreover, they foresee potential cost reduction measures and deleveraging efforts, including the sale of joint venture assets.

The analysts highlighted Celanese's considerable operating leverage, particularly as markets in the automotive, industrial, and construction sectors are poised for recovery. They noted that the current trading price of Celanese shares represents an appealing valuation, at 8.5 times the projected earnings per share for 2025.

Celanese, a global chemical and specialty materials company, has recently undergone leadership changes, with a new CEO stepping in during December. This transition is expected to influence the company's strategic direction, starting with the upcoming earnings report.

The Q4 earnings release is keenly awaited by investors, as it will not only reveal the company's performance but also provide insights into its future trajectory under new leadership. The guidance issued alongside the report will offer a glimpse into the company's expectations for the coming year, taking into account both internal initiatives and market conditions.

In summary, Deutsche Bank's stance on Celanese remains positive, with the expectation that the Q4 earnings release will clarify the company's outlook and potentially serve as a catalyst for the stock. The firm's analysis suggests that despite changes in leadership and market challenges, Celanese is well-positioned to leverage its operations for growth once key markets begin to rebound.

InvestingPro subscribers can access additional insights through the comprehensive Pro Research Report, which includes detailed analysis of Celanese's financial health, valuation metrics, and growth prospects among other key metrics.

In other recent news, Celanese Corporation has seen significant changes in its executive leadership and board, along with adjustments in analysts' outlooks. Todd Elliott, who previously retired in 2020, has been appointed to lead the Engineered Materials business.

This appointment comes as the company anticipates its next earnings release, with fourth-quarter earnings projected to drop significantly. To manage this, Celanese plans to reduce its quarterly dividend in the first quarter of 2025.

In a recent development, Christopher Kuehn from Trane Technologies (NYSE:TT) has been elected to the Celanese Board of Directors, expanding the board to 12 members. This appointment is expected to enhance the board's financial and risk management capabilities. Scott Richardson has been appointed as the new CEO, and Edward Galante has been elected as the new Chair of the Board.

Analysts at Jefferies and UBS have reduced their price targets for Celanese due to several industry challenges and concerns about the company's ability to manage its debt. Despite these challenges, Celanese remains committed to cost management and operational excellence, setting priorities for cost reduction, delivering synergies, enhancing the Engineered Materials pipeline, and leveraging the Acetyl Chain.

These are recent developments that reflect the company's determination to navigate ongoing macroeconomic difficulties.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.